TP53 and breast carcinoma: TP53 haplotype comprising of rs17878362, rs1042522 and rs186837503 for the incidence risk of post-angioplasty restenosis was evaluated by Y. L. Zee et al. They demonstrated two polymorphism combinations (–16 bp CG and +16 bp CA) as a protective haplotype [37] which was in accordance with the Hao et al. [38] studies relating to breast cancer risk (investigating rs17878362 and rs1042522), but our study did not confirm it.